BaseHealth said this week that Mostafa Ronaghi has joined its board of directors.
Currently, Ronaghi is Illumina's chief technology officer and senior vice president. Before joining Illumina, he founded several life sciences companies including ParAllele BioScience — which was acquired by Affymetrix — as well as Avantome and NextBio both of which were acquired by Illumina. He also previously spent nine years as a principal investigator at the Stanford Genome Technology Center. He is one of the inventors of pyrosequencing technology and a co-founder of Pyrosequencing AB (which was renamed Biotage).